- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/02 - Phosphorus compounds
Patent holdings for IPC class C07F 9/02
Total number of patents in this class: 470
10-year publication summary
|
33
|
35
|
19
|
14
|
19
|
11
|
15
|
16
|
15
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17594 |
14 |
| NOVA Chemicals (International) S.A. | 768 |
8 |
| Dow Technology Investments LLC | 271 |
7 |
| Gilead Sciences, Inc. | 2031 |
7 |
| Rigel Pharmaceuticals, Inc. | 539 |
7 |
| Bristol-myers Squibb Company | 4879 |
6 |
| INVISTA Technologies S.a.r.l. | 416 |
6 |
| BASF SE | 20892 |
5 |
| The Regents of the University of California | 19857 |
5 |
| Massachusetts Institute of Technology | 10030 |
5 |
| Dow Global Technologies LLC | 10401 |
5 |
| The Board of Trustees of the University of Illinois | 2685 |
5 |
| Nippon Oil Corporation | 286 |
5 |
| Vascular Biogenics Ltd. | 66 |
5 |
| International Business Machines Corporation | 61185 |
4 |
| Central Glass Company, Limited | 1264 |
4 |
| ICL-IP America Inc. | 140 |
4 |
| Lonza Ltd. | 610 |
4 |
| Evonik Oxeno GmbH & Co. KG | 313 |
4 |
| Merck Sharp & Dohme Corp. | 2200 |
3 |
| Other owners | 357 |